Quintiles Expands Clinical Development Facilities in China

Quintiles Transnational Corp. has expanded and consolidated its Global Central Laboratories and Clinical Development Services (CDS) units in Beijing, China.

The new consolidated facility in China has more than 17,000 sq. ft. of space and is located one block from the previous lab site at Sun Dong Ann Plaza in Beijing. The new facility expands the lab space by 2,600 sq. ft. The lab has 13 employees and the company plans to add to that number. CDS occupies 10,000 sq. ft. of the combined office area, up from the old facility space of less than 3,000 sq. ft. The CDS staff also continues to grow in Beijing and is expected to reach more than 60 people during the next year.

“Quintiles’ business is growing at a significant rate, and our larger facility will allow us to efficiently accommodate both the growth and our expanding test menu, which have moved well beyond basic safety testing to include specialized chemistry, PCR testing and complex flow cytometry,” said Tom Wollman, senior vice president, Global Central Laboratories.

Lai Lee Tan, head of clinical operations and general manager in China, said, “Our clinical development business is poised for rapid acceleration in China, and bringing our CDS and Global Labs businesses together will help our customers. The globalization of clinical research is continuing to increase, and China is just beginning to see the rapid growth we have experienced in India, Australia and throughout Asia Pacific.”